Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists

Details for Australian Patent Application No. 2008247441 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Stephens, Gillian; Andre, Patrick; Gao, Dacao; Phillips, David R.

Agent Davies Collison Cave

Pub. Number AU-A-2008247441

PCT Pub. Number WO2008/137793

Priority 60/915,784 03.05.07 US; 60/947,316 29.06.07 US; 60/947,289 29.06.07 US; 60/915,785 03.05.07 US

Filing date 2 May 2008

Wipo publication date 13 November 2008

International Classifications

A01N 37/10 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - Aromatic or araliphatic carboxylic acids, or thio-analogues thereof

A61K 31/19 (2006.01)

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/137793 Priority application(s): WO2008/137793

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247442-Compounds and compositions as c-kit and PDGFR kinase inhibitors

2008247439-Use of TP modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations